Position in ABUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$999,096
+$860,689 QoQ
Shares Held
208,145
+623.4% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 175 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Derivatives in ABUS
reported options exposure · as of Mar 31, 2025CallValue
$87,250
CallShares
25,000
PutValue
$87,250
PutShares
25,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. ABUS ranks #108 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in ABUS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $999,096 | 208,145 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $138,407 | 28,775 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $306,953 | 67,611 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $73,572 | 23,810 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $87,250 | 25,000 | Call | Defined | 2025-08-27 | |
| 2025-03-31 | $87,250 | 25,000 | Put | Defined | 2025-08-27 | |
| 2025-03-31 | $60,572 | 17,356 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $582,383 | 178,099 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $603,315 | 184,500 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $249,510 | 64,808 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $4,889,500 | 1,270,000 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $4,465,050 | 1,445,000 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $3,728,100 | 1,445,000 | Call | Defined | 2024-05-15 | |
| 2022-12-31 | $31,804 | 13,650 | Shares | Defined | 2023-02-14 | |
| 2021-12-31 | $155,654 | 40,014 | Shares | Defined | 2022-02-14 | |
| 2021-03-31 | $99,500 | 29,880 | Shares | Defined | 2021-05-17 | |
| 2020-06-30 | $586,449 | 322,225 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $42,665 | 42,243 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||